• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度认知障碍中的填字游戏训练与神经可塑性(COGIT-2):一项为期78周的多中心随机对照试验,涉及认知、功能、影像学和生物标志物结果。

Crossword puzzle training and neuroplasticity in mild cognitive impairment (COGIT-2): 78-week, multi-site, randomized controlled trial with cognitive, functional, imaging and biomarker outcomes.

作者信息

Wang Laura A, Goldberg Terry E, Harvey Philip D, Hanson Angela J, Motter Jeffrey, Andrews Howard, Qian Min, Zhang Renjie, Janis Meaghan, Doraiswamy P Murali, Devanand Davangere P

机构信息

Department of Psychiatry, Duke University Medical Center, Durham, North Carolina, USA.

Area Brain Aging and Mental Health, New York State Psychiatric Institute, New York, USA.

出版信息

Int J Clin Trials. 2025 Apr-Jun;12(2):111-120. doi: 10.18203/2349-3259.ijct20251032. Epub 2025 Apr 11.

DOI:10.18203/2349-3259.ijct20251032
PMID:40852373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12369482/
Abstract

BACKGROUND

Cognitive training represents an important potential therapeutic strategy for mild cognitive impairment (MCI). In our recently completed trial, crossword puzzles were superior to computerized cognitive training on Alzheimer's disease assessment scale-cognitive subscale-11 (ADAS-Cog11) and function, correlating with decreased brain atrophy over 78 weeks.

METHODS

COGIT-2 is a 78-week, multicenter, clinical trial comparing home-based, high-dose crosswords (4 puzzles per week) to low-dose crosswords (1 puzzle per week) and a health education control group in 240 MCI subjects. Crossword puzzles, administered by the CogniFit research platform, have been designed to have a moderate level of difficulty.

RESULTS

The primary outcome is change in ADAS-Cog14 and the main secondary outcome is change in informant reported daily functioning. Additional outcomes include changes in magnetic resonance imaging (MRI) hippocampal volume and cortical thickness as well as changes in plasma neurofilament light and plasma pTau217.

CONCLUSIONS

If the efficacy of computerized crossword puzzle training is confirmed in COGIT-2, crosswords training could become a low-cost, home-based, scalable, cognitive enhancement tool for people at risk for Alzheimer's disease. The dose comparison will provide useful information on the preferred frequency of crossword puzzle training.

TRIAL REGISTRATION

Trial registration number ClinicalTrials.gov identifier (NCT06601933).

摘要

背景

认知训练是治疗轻度认知障碍(MCI)的一项重要潜在策略。在我们最近完成的试验中,填字游戏在阿尔茨海默病评估量表-认知分量表-11(ADAS-Cog11)及功能方面优于计算机化认知训练,且与78周内脑萎缩减少相关。

方法

COGIT-2是一项为期78周的多中心临床试验,在240名MCI受试者中,将居家高剂量填字游戏(每周4个谜题)与低剂量填字游戏(每周1个谜题)及一个健康教育对照组进行比较。由CogniFit研究平台提供的填字游戏设计为中等难度水平。

结果

主要结局指标是ADAS-Cog14的变化,主要次要结局指标是 informant报告的日常功能变化。其他结局指标包括磁共振成像(MRI)海马体积和皮质厚度的变化,以及血浆神经丝轻链和血浆pTau217的变化。

结论

如果计算机化填字游戏训练的疗效在COGIT-2中得到证实,填字游戏训练可能会成为一种低成本、居家、可扩展的认知增强工具,用于有患阿尔茨海默病风险的人群。剂量比较将为填字游戏训练的最佳频率提供有用信息。

试验注册

试验注册号ClinicalTrials.gov标识符(NCT06601933)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0eb/12369482/385bb0cd6b2d/nihms-2098085-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0eb/12369482/a39935da889b/nihms-2098085-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0eb/12369482/385bb0cd6b2d/nihms-2098085-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0eb/12369482/a39935da889b/nihms-2098085-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0eb/12369482/385bb0cd6b2d/nihms-2098085-f0002.jpg

相似文献

1
Crossword puzzle training and neuroplasticity in mild cognitive impairment (COGIT-2): 78-week, multi-site, randomized controlled trial with cognitive, functional, imaging and biomarker outcomes.轻度认知障碍中的填字游戏训练与神经可塑性(COGIT-2):一项为期78周的多中心随机对照试验,涉及认知、功能、影像学和生物标志物结果。
Int J Clin Trials. 2025 Apr-Jun;12(2):111-120. doi: 10.18203/2349-3259.ijct20251032. Epub 2025 Apr 11.
2
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.用于治疗早期阿尔茨海默病的布拉克美辛:ANAVEX2-73-AD-004 IIB/III期试验结果
J Prev Alzheimers Dis. 2025 Jan;12(1):100016. doi: 10.1016/j.tjpad.2024.100016. Epub 2025 Jan 1.
3
Galantamine for Alzheimer's disease.加兰他敏用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2001(4):CD001747. doi: 10.1002/14651858.CD001747.
4
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
5
Galantamine for Alzheimer's disease.加兰他敏用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2002(3):CD001747. doi: 10.1002/14651858.CD001747.
6
Galantamine for Alzheimer's disease and mild cognitive impairment.加兰他敏用于治疗阿尔茨海默病和轻度认知障碍。
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD001747. doi: 10.1002/14651858.CD001747.pub3.
7
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
8
Folic acid with or without vitamin B12 for cognition and dementia.叶酸联合或不联合维生素B12对认知及痴呆的影响
Cochrane Database Syst Rev. 2003(4):CD004514. doi: 10.1002/14651858.CD004514.
9
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
10
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.

本文引用的文献

1
Japan-Multimodal Intervention Trial for the Prevention of Dementia: A randomized controlled trial.日本多模式干预预防痴呆症试验:一项随机对照试验。
Alzheimers Dement. 2024 Jun;20(6):3918-3930. doi: 10.1002/alz.13838. Epub 2024 Apr 22.
2
MRI measurements of brain hippocampus volume in relation to mild cognitive impairment and Alzheimer disease: A systematic review and meta-analysis.MRI 测量脑内海马体体积与轻度认知障碍和阿尔茨海默病的关系:系统评价和荟萃分析。
Medicine (Baltimore). 2023 Sep 8;102(36):e34997. doi: 10.1097/MD.0000000000034997.
3
Computerized Games versus Crosswords Training in Mild Cognitive Impairment.
轻度认知障碍中电脑游戏与填字游戏训练的对比
NEJM Evid. 2022 Dec;1(12). doi: 10.1056/evidoa2200121. Epub 2022 Oct 27.
4
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
5
Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial.计算机化认知训练对阿尔茨海默病高危人群默认模式网络连通性的影响:一项 78 周的随机对照试验。
J Alzheimers Dis. 2023;91(1):483-494. doi: 10.3233/JAD-220946.
6
Comparing the effects of olfactory-based sensory stimulation and board game training on cognition, emotion, and blood biomarkers among individuals with dementia: A pilot randomized controlled trial.比较嗅觉感官刺激和棋盘游戏训练对痴呆症患者认知、情绪和血液生物标志物的影响:一项初步随机对照试验。
Front Psychol. 2022 Sep 20;13:1003325. doi: 10.3389/fpsyg.2022.1003325. eCollection 2022.
7
Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes.比较血浆神经丝轻链和总 tau 作为神经退行性变标志物:与认知和神经影像学结果的关联。
Alzheimers Res Ther. 2021 Dec 14;13(1):199. doi: 10.1186/s13195-021-00944-y.
8
Randomized Controlled Trial of a Cognitive Intervention to Improve Memory in Heart Failure.一项改善心力衰竭患者记忆力的认知干预随机对照试验。
J Card Fail. 2022 Apr;28(4):519-530. doi: 10.1016/j.cardfail.2021.10.008. Epub 2021 Nov 8.
9
Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.阿尔茨海默病中血液磷酸化 tau181 和神经丝轻链与神经退行性变的纵向关联。
JAMA Neurol. 2021 Apr 1;78(4):396-406. doi: 10.1001/jamaneurol.2020.4986.
10
Does Visual Speed of Processing Training Improve Health-Related Quality of Life in Assisted and Independent Living Communities?: A Randomized Controlled Trial.视觉处理速度训练能否改善辅助生活社区和独立生活社区中与健康相关的生活质量?一项随机对照试验。
Innov Aging. 2020 Jul 31;4(4):igaa029. doi: 10.1093/geroni/igaa029. eCollection 2020.